Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphoblastic leukemia (T-ALL), including early T-cell precursor ALL (ETP-ALL) cases with poor prognosis. Lmo2 must be recruited to DNA by binding to the hematopoietic basic helix-loop-helix factors Scl/Tal1 o...
Main Authors: | McCormack, M, Shields, B, Jackson, J, Nasa, C, Shi, W, Slater, N, Tremblay, C, Rabbitts, T, Curtis, D |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2013
|
相似书籍
-
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
由: McCormack, M, et al.
出版: (2004) -
The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
由: McCormack, M, et al.
出版: (2010) -
Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements
由: Irene Homminga, et al.
出版: (2012-02-01) -
Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
由: Virginie Deleuze, et al.
出版: (2012-01-01) -
The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
由: McCormack, M, et al.
出版: (2003)